These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8612670)

  • 1. Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher's disease.
    Mariani G; Molea N; La Civita L; Porciello G; Lazzeri E; Ferri C
    Eur J Nucl Med; 1996 Apr; 23(4):466-70. PubMed ID: 8612670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
    Mariani G; Filocamo M; Giona F; Villa G; Amendola A; Erba P; Buffoni F; Copello F; Pierini A; Minichilli F; Gatti R; Brady RO
    J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone involvement in Gaucher's disease: 'bone crisis' or disease complication?
    La Civita L; Mariani G; Porciello G; Viacava P; Molea N; Lazzeri E; Pasero G; Ferri C
    Clin Exp Rheumatol; 1996; 14(2):195-8. PubMed ID: 8737728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone, bone marrow, and MIBI scintigraphic findings in Gaucher's disease "bone crisis".
    Blocklet D; Abramowicz M; Schoutens A
    Clin Nucl Med; 2001 Sep; 26(9):765-9. PubMed ID: 11507294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-MDP Bone Scintigraphy in Gaucher Disease.
    Kesim S; Turoglu HT; Tutar E; Ozguven S; Erdil TY
    Clin Nucl Med; 2020 Oct; 45(10):e455-e456. PubMed ID: 32604108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m sestamibi bone marrow scintigraphy in Gaucher disease.
    Aharoni D; Krausz Y; Elstein D; Hadas-Halpern I; Zimran A
    Clin Nucl Med; 2002 Jul; 27(7):503-9. PubMed ID: 12072778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosis].
    Urso S; Pacciani E; Fariello G; Colajacomo M; Fassari FM; Randisi F; Certo A; Liberatore M; Pagnotta G
    Radiol Med; 1995 Sep; 90(3):212-8. PubMed ID: 7501824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiopharmacology of inhaled 133Xe in skeletal sites containing deposits of Gaucher cells.
    Castronovo FP; McKusick KA; Doppelt SH; Barton NW
    Nucl Med Biol; 1993 Jul; 20(5):707-14. PubMed ID: 8358357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
    Payne JK; Trivedi MH; Devous MD
    J Nucl Med; 1996 Oct; 37(10):1735-40. PubMed ID: 8862321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
    Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
    Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant technetium-99m-MIBI and technetium-99m-HMPAO uptake of recurrent occipital meningioma on brain SPECT images.
    Shih WJ; Lee JK; Milan P
    J Nucl Med; 1996 Jul; 37(7):1183-5. PubMed ID: 8965195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic osteomyelitis: diagnosis with technetium-99m-d, l-hexamethylpropylene amine oxime labelled leucocytes.
    Krznaric E; Roo MD; Verbruggen A; Stuyck J; Mortelmans L
    Eur J Nucl Med; 1996 Jul; 23(7):792-7. PubMed ID: 8662118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scintigraphic appearances of Gaucher's disease].
    Okada J; Uchiyama G; Hayakawa K; Araki T; Hayashi S; Yamada K; Seto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 May; 45(5):717-20. PubMed ID: 3863094
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature.
    Mikosch P; Kohlfürst S; Gallowitsch HJ; Kresnik E; Lind P; Mehta AB; Hughes DA
    Nuklearmedizin; 2008; 47(6):239-47. PubMed ID: 19057797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic findings in Gaucher's disease.
    Israel O; Jerushalmi J; Front D
    J Nucl Med; 1986 Oct; 27(10):1557-63. PubMed ID: 3760980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 99mTc-MIBI and 99mTc-MDP administration on dual-energy X-ray absorptiometry bone mineral density measurements.
    Gumuser G; Parlak Y; Topal G; Aras F; Ruksen E; Sayit E
    Nucl Med Commun; 2009 Jun; 30(6):445-8. PubMed ID: 19357550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy.
    Hermann G; Goldblatt J; Levy RN; Goldsmith SJ; Desnick RJ; Grabowski GA
    AJR Am J Roentgenol; 1986 Nov; 147(5):943-8. PubMed ID: 3490167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic evaluation of Tc-99m-low-density lipoprotein (LDL) distribution in patients with Gaucher disease.
    Lorberboym M; Vallabhajosula S; Lipszyc H; Pastores G
    Clin Genet; 1997 Jul; 52(1):7-11. PubMed ID: 9272706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-sestamibi scintigraphy to monitor the long-term efficacy of enzyme replacement therapy on bone marrow infiltration in patients with Gaucher disease.
    Erba PA; Minichilli F; Giona F; Linari S; Dambrosia J; Pierini A; Filocamo M; Di Rocco M; Buffoni F; Brady RO; Mariani G
    J Nucl Med; 2013 Oct; 54(10):1717-24. PubMed ID: 23990684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.